EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
EY Romania provided financial and tax advisory services to the Italian company Fidia Farmaceutici S.p.A. in the process of acquiring Meditrina Pharmaceuticals S.R.L.
EY Romania provided financial and tax advisory services to the Italian company Fidia Farmaceutici S.p.A. in the process of acquiring Meditrina Pharmaceuticals S.R.L., a Romanian pharmaceutical distributor active in therapeutic areas such as dermatology, gynecology, urology, and nephrology.
Fidia Farmaceutici S.p.A., headquartered in Abano Terme, Italy, is a long-standing pharmaceutical company specializing in regenerative medicine and the use of hyaluronic acid in advanced therapeutic applications.
We are honored to have supported Fidia Farmaceutici S.p.A. in. The acquisition of Meditrina Pharmaceuticals marks an important step in strengthening Fidia’s presence on the Romanian market. This is a strategic transaction and reflects investors’ confidence in the potential of the local pharmaceutical sector. I would like to thank the joint EY team for their professionalism and dedication throughout the entire process.
The EY team advising on this transaction was coordinated by Liliana Bușoiu and Alexandra Bulei for the financial due diligence component, and by Miruna Enache and Carmen Afanasenco for tax advisory.